At Home Drug Testing and The Future of Telemedicine
“Before the first COVID-19 case in the United States, a different epidemic—the opioid crisis—was taking the lives of 130 Americans per day. Although the pandemic threatens everyone, it is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery.”
According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults (aged 12 and older) battled a substance use disorder in 2017.
Could the relative risk of patients with substance use disorder who are not receiving the standard of care intersect with the relative risk of COVID-19?
LEARN MORE ABOUT AT HOME DRUG TESTING BY CONTACTING US: https://genotoxlabs.com/contact-us/
ABOUT GENOTOX LABS:
At Genotox Laboratories, we’re devoted to providing healthcare professionals with accurate, dependable, and actionable toxicology and pharmacogenetics services. We serve pain physicians, family practices, internal medicine, psychiatrists, addiction specialists, OB/GYN, and recovery centers.
With 27 combined years of experience as a board-certified anesthesiologist and pain medicine physician, Matthew McCarty, MD became aware of the growing need for enhanced medication monitoring and personalized medicine. As a result, he founded Genotox Laboratories in 2012.
After extensive use of toxicology testing in his practice, Dr. McCarty realized that a better screening assay was essential for verifying UDT sample authenticity. Leveraging the power of molecular diagnostic testing, he invented and co-developed ToxProtect, the first patent pending DNA-authenticated urine drug test.
TAGS: Remote Urine Test, Drug Test, No Contact Drug Test, ToxDirect